Hepatitis B

Hepatitis B News

  • Alert FDA OKs 8-Week Mavyret for Hepatitis C Glecaprevir/pibrentasvir is the first HCV treatment of this duration approved for genotypes 1 through 6 in previously untreated adults without cirrhosis.
  • FDA Panel Supports Licensing Two-Dose Hep B Vaccine Concerns of a possible link with myocardial infarction remain, but benefits beat risks, the committee says. Members call for clearer design with the postmarketing study the company proposes.
 

Hepatitis B Perspective

 

Journals